Zepbound cost: Lilly's self-pay price and the refill rule

Zepbound is tirzepatide, made by Eli Lilly, approved for weight management and for obstructive sleep apnea in adults with obesity. Lilly sells it to self-pay patients through LillyDirect. Every price here was read from Lilly's or the clinic's own page and re-checked on October 12, 2026, the day this page was published.

What Zepbound is approved for

In Lilly's words, Zepbound is used with a reduced-calorie diet and more physical activity to help adults with "obesity, or some adults with overweight who also have weight-related medical problems, to lose excess body weight and keep the weight off," and adults with "moderate-to-severe obstructive sleep apnea (OSA) and obesity to improve their OSA."

Zepbound's self-pay price, from Eli Lilly

From LillyDirect, for the single-dose vial and the KwikPen. Lilly defines a month as 28 days.

Dose	Self-pay price	If you don't refill within 45 days
2.5 mg (starting dose)	Starting at $299 a month	not tied to refill timing
5 mg	Starting at $399 a month	not tied to refill timing
7.5 mg	Starting at $449 a month	$499
10 mg, 12.5 mg, 15 mg	Starting at $449 a month	$699

The $449 at the higher doses is conditional. Lilly lists it "when you refill within 45 days," and its terms say "Regular prices will apply if prescription is not refilled within 45 days ($499 for 7.5mg, $699 for 10mg, $699 for 12.5mg, and $699 for 15mg)." A late refill at 10 mg or above costs $250 a month more.

If you have insurance or Medicare

What Lilly says, and nothing beyond it:

• Commercial insurance. Lilly's savings card lets eligible patients "Pay as low as $25" "per month for up to a 3-month prescription." It excludes government beneficiaries, which Lilly says include "any state, federal, or government funded healthcare program, like Medicaid, Medicare."
• Medicare. Lilly's Medicare GLP-1 Bridge page says "the Medicare GLP-1 Bridge program allows you to access select weight loss medicines for just $50 per month," with a "$50 cost to you after prior authorization (PA) approval," for people "Covered through Medicare Part D." It covers "Zepbound (tirzepatide) Single-Patient-Use KwikPen for weight management," and "Zepbound Single-Dose Pen and Single-Dose Vial are not covered." Lilly marks the program "Valid July 2026–December 2027."

Getting Zepbound online

LillyDirect fills prescriptions but does not write them. Of the online clinics we track that list brand Zepbound:

• Sesame describes the route directly: its Zepbound page refers to "when your Sesame provider sends your Rx to the LillyDirect pharmacy." Its care fee is $59 a month on a 12-month commitment or $99 a month month to month, billed every 28 days, with the medication paid separately. Sesame is an affiliate partner.
• MEDGm lists "$99 membership + medication cost" for Zepbound, without publishing the medication cost or where it is bought. MEDGm is an affiliate partner.
• Bundles that include the drug: RxSpan MD at $1,069 "for the first month" (affiliate partner); Luvo Health at $1,399 per 4 weeks; He & She MD at $1,399 a month, priced for a 12-month supply; Fridays at $1,828 a month, month to month.

Against Lilly's own $299 to $449, the bundles cost roughly two to six times as much. They include the clinician, which LillyDirect does not, so the fair comparison is a bundle against Lilly's price plus a prescription, such as Sesame's care fee.

If you are comparing Zepbound with Ozempic, they are different drugs with different approvals; our Ozempic vs Zepbound guide covers what the trials show.